BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.